The current price of GRAL is $120.41 — it has increased by 1.07% since the previous close. Data as of Nov 6, 2026.
GRAL is down 20.77% over the past week, down 12.23% over the past month and up 50.51% over the past year. The price is above its 200-day moving average of $78.76.
Analysts' average 12-month price target for GRAL is $115.29, which implies 4.25% downside from the current price. Individual estimates range from $60.00 to $175.00.
Of the 10 analysts covering GRAIL Inc., 5 rate it a buy and 5 rate it a hold. The overall consensus is neutral. Analyst ratings are opinions and do not guarantee future performance.
GRAIL Inc. has a market capitalization of $5.38B. The company belongs to the Healthcare sector. Compare it with other companies in the stock screener.
In its most recent quarterly report, GRAIL Inc. posted a loss of $2.21 per share against an estimate of -$2.45, beating expectations by 9.80%. Upcoming reports are listed in the earnings calendar.
GRAIL Inc. reported revenue of $37.54M in its most recent quarter, which has increased by 3.71% compared with the same quarter a year earlier. Analysts had expected $44.21M.
GRAIL Inc. has not paid any dividends over the past year.
In the latest trading session GRAL moved between $117.00 and $129.70, a range of 10.55% of its current price.
Investing in stocks requires thorough research: study the company's financials, related news and technical analysis before making a decision. Technical analysis of GRAIL Inc. shows a sell rating today and a buy rating on the weekly timeframe. Technical ratings are indicators, not investment advice.
Over the past 52 weeks GRAL has traded between $41.50 and $166.48. The current price is 27.67% below its 52-week high.
Figures as of Nov 6, 2026. This information is provided for general purposes only and is not investment advice.